2Enzinger P CMayer R J.Esophageal cancer[J].N Engl J Med 2003,349:2241-2252.
3Duffaud FTherasse P.[New guidelines to evaluate the response to treatment in solid tumors][J].Bull Cancer 2000,87:881-886.
4Hanauske A R,Chen V,Paoletti P,et al.Pemetrexed disodium:a novel antifolate clinically active against multiple solid tumors[J].Oncologist 2001,6:363-373.
5Hanna N,Shepherd F A,Fossella F V,et al.Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy[J].J Clin Oncol 2004,22:1589-1597.
6Scagliotti G V,Parikh P,von Pawel J,et al.Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer[J].J Clin Oncol 2008,26:3543-3551.
7Vogelzang N J,Rusthoven J J,Symanowski J,et al.Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma[J].J Clin Oncol 2003,21:2636-2644.
8Miller A B,Hoogstraten B,Staquet M,et al.Reporting results of cancer treatment[J].Cancer,1981,47(1):207-214.
9Millar J,Scullin P,Morrison A.Phase Ⅱ study of gemcitabine and cisplatin in locally advanced/metastatic oesophageal cancer[J].Br J Cancer,2005,93(10):1112-1116.
10Kroep J R,pinedo H M,Giaccone G,et al.Phase Ⅱ study of cisplatin preceding gemcitabine in patients with advanced oesophageal cancer[J].Am Oncol,2004,15 (2):230-235.
